Biotech Pfizer, in a rare COVID-19 setback, dumps
Post# of 1418
(Total Views: 332)
Posted On: 02/10/2022 5:47:50 PM
Biotech Pfizer, in a rare COVID-19 setback, dumps Paxlovid's intravenous sibling in further blow to ACTIV-3
https://www.fiercebiotech.com/biotech/pfizer-...v-3-future
Maybe they now want to partner with Todos since they got nothing for hospitalized patients?
Gerald Commissiong @G_Commish - 29m
"No surprise - antiviral alone cannot work late stage COVID. Must address cytokine storm AND SARS-CoV-2 that causes hyper-innate immune reaction that causes the storm - both same time. #Tollovir is the only dual mechanism anti-3CL/anti-cytokine. Preparing for EUAs ex-US and Ph3 "
https://www.fiercebiotech.com/biotech/pfizer-...v-3-future
Maybe they now want to partner with Todos since they got nothing for hospitalized patients?
Gerald Commissiong @G_Commish - 29m
"No surprise - antiviral alone cannot work late stage COVID. Must address cytokine storm AND SARS-CoV-2 that causes hyper-innate immune reaction that causes the storm - both same time. #Tollovir is the only dual mechanism anti-3CL/anti-cytokine. Preparing for EUAs ex-US and Ph3 "
(1)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼